Skip to content
10-Q

Quarterly Report

Medicale Corp. MCLE

0001683168-25-003660

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · May 12, 2025 5.92M sh
Shares Diluted Q2 2025 · Mar 31, 2025 5.92M sh
Shares Diluted Q2 2025 · Mar 31, 2025 5.92M sh
Shares Diluted Q2 2025 · Mar 31, 2024 5.92M sh
Shares Diluted Q2 2025 · Mar 31, 2024 5.92M sh
Operating Cash Flow Q2 2025 · Mar 31, 2025 −$14.53K
Operating Cash Flow Q2 2025 · Mar 31, 2024 −$58.79K
Stockholders Equity Q2 2025 · Mar 31, 2025 −$123.89K
Stockholders Equity Q2 2025 · Dec 31, 2024 −$115.61K
Stockholders Equity Q2 2025 · Sep 30, 2024 −$98.93K
Stockholders Equity Q2 2025 · Mar 31, 2024 −$71.59K
Stockholders Equity Q2 2025 · Dec 31, 2023 −$60.03K
Stockholders Equity Q2 2025 · Sep 30, 2023 −$40.72K
Current Liabilities Q2 2025 · Mar 31, 2025 $25.93K
Current Liabilities Q2 2025 · Sep 30, 2024 $15.51K
Total Liabilities Q2 2025 · Mar 31, 2025 $123.89K
Total Liabilities Q2 2025 · Sep 30, 2024 $99.09K
Current Assets Q2 2025 · Mar 31, 2025 $0
Current Assets Q2 2025 · Sep 30, 2024 $159
Total Assets Q2 2025 · Mar 31, 2025 $0
Total Assets Q2 2025 · Sep 30, 2024 $159
Eps Diluted Q2 2025 · Mar 31, 2025 $0.00
Eps Diluted Q2 2025 · Mar 31, 2025 $0.00
Eps Diluted Q2 2025 · Mar 31, 2024 $0.00
Eps Diluted Q2 2025 · Mar 31, 2024 −$0.01
Eps Basic Q2 2025 · Mar 31, 2025 $0.00
Eps Basic Q2 2025 · Mar 31, 2025 $0.00
Eps Basic Q2 2025 · Mar 31, 2024 $0.00
Eps Basic Q2 2025 · Mar 31, 2024 −$0.01
Sga Expense Q2 2025 · Mar 31, 2025 $6.27K
Sga Expense Q2 2025 · Mar 31, 2025 $21.26K
Sga Expense Q2 2025 · Mar 31, 2024 $10.6K
Sga Expense Q2 2025 · Mar 31, 2024 $29.91K
Net Income Q2 2025 · Mar 31, 2025 −$8.28K
Net Income Q2 2025 · Mar 31, 2025 −$24.96K
Net Income Q2 2025 · Dec 31, 2024 −$16.68K
Net Income Q2 2025 · Mar 31, 2024 −$11.56K
Net Income Q2 2025 · Mar 31, 2024 −$30.87K
Net Income Q2 2025 · Dec 31, 2023 −$19.31K
Operating Income Q2 2025 · Mar 31, 2025 −$6.27K
Operating Income Q2 2025 · Mar 31, 2025 −$21.26K
Operating Income Q2 2025 · Mar 31, 2024 −$10.6K
Operating Income Q2 2025 · Mar 31, 2024 −$29.91K